Find Ravidasvir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ravidasvir [usan], 1242087-93-9, Ppi-668 free base, Al3g001bi8, Bi 238630, Bi-238630
Molecular Formula
C42H50N8O6
Molecular Weight
762.9  g/mol
InChI Key
LCHMHYPWGWYXEL-ZYADHFCISA-N
FDA UNII
AL3G001BI8

Ravidasvir
Ravidasvir is under investigation in clinical trial NCT02961426 (Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection).
1 2D Structure

Ravidasvir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl N-[(2S)-1-[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
2.1.2 InChI
InChI=1S/C42H50N8O6/c1-23(2)35(47-41(53)55-5)39(51)49-17-7-9-33(49)37-43-22-32(46-37)29-14-13-25-19-26(11-12-27(25)20-29)28-15-16-30-31(21-28)45-38(44-30)34-10-8-18-50(34)40(52)36(24(3)4)48-42(54)56-6/h11-16,19-24,33-36H,7-10,17-18H2,1-6H3,(H,43,46)(H,44,45)(H,47,53)(H,48,54)/t33-,34-,35-,36-/m0/s1
2.1.3 InChI Key
LCHMHYPWGWYXEL-ZYADHFCISA-N
2.1.4 Canonical SMILES
CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
2.1.5 Isomeric SMILES
CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)[C@@H]7CCCN7C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
2.2 Other Identifiers
2.2.1 UNII
AL3G001BI8
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ppi-668

2.3.2 Depositor-Supplied Synonyms

1. Ravidasvir [usan]

2. 1242087-93-9

3. Ppi-668 Free Base

4. Al3g001bi8

5. Bi 238630

6. Bi-238630

7. Carbamic Acid, N-((1s)-1-(((2s)-2-(5-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-1h-benzimidazol-6-yl)-2-naphthalenyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)-, Methyl Ester

8. Methyl N-((1s)-1-(((2s)-2-(5-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3- Methylbutanoyl)pyrrolidin-2-yl)-1h-imidazol-4-yl)naphthalen-2-yl)-1h-benzimidazol-2-yl)pyrrolidin-1-yl)carbonyl)-2-methylpropyl)carbamate

9. Methyl N-[(2s)-1-[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3h-benzimidazol-5-yl]naphthalen-2-yl]-1h-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

10. Carbamic Acid, N-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, Methyl Ester

11. Unii-al3g001bi8

12. Ravidasvir Free Base

13. Bl-238630

14. Ravidasvir [inn]

15. Ravidasvir [who-dd]

16. Schembl7603463

17. Chembl3121849

18. Schembl12075676

19. Bdbm243443

20. Dtxsid401335997

21. Us9427428, 3

22. Q27273972

23. Methyl ((1s)-1-(((2s)-2-(4-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-benzimidazol-5-yl)-2-naphthyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate

24. Methyl N-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate

25. Methyl((1s)-1-(((2s)-2-(4-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-benzimidazol-5-yl)-2-naphthyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate

26. Methyl((s)-1-((s)-2-(5-(6-(2((s)-1-((methoxycarbonyl)-l-valyl)pyrrolidin-2-yl)-1h-imidazol-4-yl)naphthalen-2-yl)-1h-benzo[d]imidazol-2-yl) Pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

27. Methyln-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate

2.4 Create Date
2011-06-06
3 Chemical and Physical Properties
Molecular Weight 762.9 g/mol
Molecular Formula C42H50N8O6
XLogP36.1
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count8
Rotatable Bond Count12
Exact Mass762.38533134 g/mol
Monoisotopic Mass762.38533134 g/mol
Topological Polar Surface Area175 Ų
Heavy Atom Count56
Formal Charge0
Complexity1400
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty